UniProtKB/Swiss-Prot Q9HD67: Variant p.Ser1663Thr

Unconventional myosin-X
Gene: MYO10
Feedback?

Variant information Variant position:

1663 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Serine (S) to Threonine (T) at position 1663 (S1663T, p.Ser1663Thr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from small size and polar (S) to medium size and polar (T) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs25901 [ dbSNP | Ensembl ]

Sequence information Variant position:

1663 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

2058 The length of the canonical sequence.
Location on the sequence:

RGILKYLKFHLKRIREQFPG S EMEKYALFTYESLKKTKCRE The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         RGILKYLKFHLKRIREQFPGSEMEKYALFTYESLKKTKCRE

Mouse                         RGILKYLKFHLKRIREQFPGTEMEKYALFIYESLKKTKCRE

Rat                           RGILKYLKFHLKRIREQFPGTEMEKYALFIYESLKKTKCRE

Bovine                        RGILKYLKFHLRRIREQFPGTEMEKYALFIYESLKKTKCRE

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 2058	Unconventional myosin-X
Domain	1547 – 1695	MyTH4
Alternative sequence	98 – 2058	Missing. In isoform 2.
Mutagenesis	1647 – 1647	K -> D. Abolishes interaction with tubulin; when associated with D-1650.
Mutagenesis	1650 – 1650	K -> D. Abolishes interaction with tubulin; when associated with D-1647.

Literature citations
Myosin-X, a novel myosin with pleckstrin homology domains, associates with regions of dynamic actin.
Berg J.S.; Derfler B.H.; Pennisi C.M.; Corey D.P.; Cheney R.E.;
J. Cell Sci. 113:3439-3451(2000)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); SUBCELLULAR LOCATION; TISSUE SPECIFICITY; VARIANTS TRP-324 AND THR-1663; The tumor-sensitive calmodulin-like protein is a specific light chain of human unconventional myosin X.
Rogers M.S.; Strehler E.E.;
J. Biol. Chem. 276:12182-12189(2001)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); VARIANTS TYR-148 AND THR-1663; INTERACTION WITH CALM3/CLP; Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.
Nagase T.; Ishikawa K.; Suyama M.; Kikuno R.; Miyajima N.; Tanaka A.; Kotani H.; Nomura N.; Ohara O.;
DNA Res. 5:277-286(1998)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1); VARIANT THR-1663; The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
The MGC Project Team;
Genome Res. 14:2121-2127(2004)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2); VARIANT THR-1663;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.